San Diego-based CureScience Institute, a non-profit organization dedicated to accelerating novel curative therapies, disclosed on Tuesday that Dr Boris Reznik has been appointed as an Advisory Board member.
Dr Reznik is chairman of Venvalo Group, venture value optimization firm and is a veteran of several startups.
According to CureScience Institute, Dr Reznik has a strong track record of building companies across a diverse set of technologies-based industries, primarily focused on biomedical sciences.
CEO of CureScience Institute, Dr Shashaanka Ashili, commented: "I am delighted to welcome Dr Reznik to our Advisory Board," adding "He brings a unique experience in accelerating drug and device development for life sciences companies. We at CureScienceTM look forward to benefiting from Dr Reznik's counsel as we work towards developing personalized therapeutic approaches."
Eurofins Launches At-Home COVID-19 PCR Test kit Available Direct to Consumers
Olympus Corporation exercises call option for the acquisition of Medi-Tate Ltd, Israel
Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization
MatMaCorp's COVID-19 2SF RNA Test Effective in Detecting Variants
Minnesota Medical Technologies signs distribution agreement with Wellspect Healthcare
Non-Invasive Vagus Nerve Stimulation Enters New Stage of COVID-19 Research
Locate Bio wins FDA breakthrough device designation for the regenerative product Chondro3
CureScience Institute announces appointment of Dr Boris Reznik as member of Advisory Board